Pfizer will sell U.S. 100 million more vaccine doses

(Image credit: Getty Images)

Pfizer and BioNTech will sell the U.S. an additional 100 million doses of their COVID-19 vaccine, the drugmakers said Wednesday.

At least 70 million doses will be delivered by June 30, and the rest will come by July 31, according to the terms of the $2 billion deal. The U.S. can also opt to buy another 400 million doses, The Associated Press reports.

Pfizer's vaccine is 95 percent effective in preventing transmission of coronavirus. It was the first to gain FDA approval, and is being distributed across the U.S. The Trump administration purchased 100 million vaccine doses from Pfizer over the summer, as well as 100 million from Moderna, and millions more from developers still testing their vaccines. Reports indicated Pfizer had later offered the U.S. an additional 100 million doses, but the Trump administration turned them down, meaning the U.S. wouldn't get more Pfizer doses until the summer.

The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE

https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Explore More

Kathryn is a graduate of Syracuse University, with degrees in magazine journalism and information technology, along with hours to earn another degree after working at SU's independent paper The Daily Orange. She's currently recovering from a horse addiction while living in New York City, and likes to share her extremely dry sense of humor on Twitter.